Don't Miss Out on ellacor Updates!
Be in the know about the most anticipated aesthetic procedure.
Cytrellis Biosystems, Inc. (“Cytrellis”) is committed to maintaining the privacy of your personal information collected through this website, www.cytrellis.com (the “Website”). This Privacy Policy discloses Cytrellis’s information collection and dissemination practices in connection with the Website and applies solely to the information that we collect through the Website. This Privacy Policy does not address personal information that you provide to us in other contexts (e.g., through a business or investment relationship not handled through the Website).
By using the Website, you signify your acceptance of this Privacy Policy. If you do not agree to the terms of this Privacy Policy, please do not use this Website. Your continued use of the Website following the posting of changes to these terms will mean that you accept those changes.
This Privacy Policy covers how Cytrellis treats personal information (“PI”) that it collects and receives through this Website. PI is information about you that is personally identifiable (e.g., your name, address, e-mail address or phone number) and is not otherwise publicly available.
How Personal Information Provided By You May Be Used.
Except as described in this Privacy Policy, Cytrellis only collects your PI through this Website when you choose to provide such information, such as when you enter your e-mail address to use the “Contact Us” feature. PI can include your name or e-mail address. Cytrellis may use your PI to:
Cytrellis will not sell, rent, license, or trade your PI with third parties for their own direct marketing use unless we receive your express consent to do so. Unless you give us permission to do so, Cytrellis will not share your PI other than as specified in this Privacy Policy.
Disclosures to Third Parties Assisting In Our Operations. Cytrellis may share your PI under confidentiality agreements with other companies that work with, or on behalf of, Cytrellis, to provide products and services. These companies may use your PI to assist Cytrellis in its operations. These companies do not, however, have any independent right to share this information. Disclosures Under Special Circumstances. We may disclose your PI to respond to subpoenas, court orders, legal process or governmental regulations, or to establish or exercise our legal rights or defend against legal claims. We may also disclose your PI if we believe it is necessary to share information in order to investigate, prevent or take action regarding illegal activities, suspected fraud, situations involving potential threats to the physical safety of any person, or as otherwise required by law.
Business Transfers. We may share your PI with other business entities in connection with the sale, assignment, merger or other transfer of all or a portion of Cytrellis’s business to such business entity. We will require any such successor business entity to honor the terms of this Privacy Policy.
Each time a visitor comes to the Website, Cytrellis collects some information to improve the overall quality of the visitor’s online experience.
Aggregated Data. Cytrellis collects aggregate queries for internal reporting and also counts, tracks, and aggregates the visitor’s activity into Cytrellis’s analysis of general traffic-flow at the Website. Cytrellis may also remove personal identifiers from PI and maintain it in aggregate form that may later be combined with other information to generate anonymous, aggregated statistical information. Cytrellis may share, publicly or privately, anonymized or aggregated information from the Website. If Cytrellis shares aggregate information, it will do so in a manner that no individual can be identified.
Web Server Logs and IP Addresses. An Internet Protocol (“IP”) address is a number that automatically identifies the computer/device you have used to access the Internet. The IP address enables our server to send you the web pages that you want to visit, and it may disclose the server owned by your Internet Service Provider. Cytrellis may use IP addresses to conduct website analyses and performance reviews and to administer the Website.
Cookies and Web Beacons. Cookies are pieces of information that a website transfers to a user’s computer for purposes of storing information about a user’s preferences.
Cookies in and of themselves do not personally identify users, although they do identify a user’s computer. Many websites use cookies as a standard practice to provide useful features when a user visits the website and most web browsers are set up to accept cookies. Cytrellis uses cookies to improve your online experience when visiting the Website. You can set your browser to refuse cookies, but some portions of the Website may not work properly if you refuse cookies. Some of the Website’s web pages may use web beacons in conjunction with cookies to compile aggregate statistics about website usage. A web beacon is an electronic image (also referred to as an “action tag,” “single-pixel,” or “clear GIF”) that is commonly used to track the traffic patterns of users from one web page to another in order to maximize web traffic flow and to otherwise analyze the effectiveness of websites. Some web beacons may be unusable if you elect to reject their associated cookies.
The Website may contain links to third-party websites that may offer information of interest. This Privacy Policy does not apply to those websites, and Cytrellis recommends reviewing those websites’ privacy policies individually. Cytrellis assumes no responsibility for any material outside of the Website, including any website that may be accessed through a link from the Website.
Cytrellis takes measures it believes are reasonably designed to protect the PI it receives from you from unauthorized access, use and alteration. We believe, however, that a persistent attacker with sufficient resources would be able to defeat our security measures. Therefore, we provide no guarantee that your PI will remain secure.
Some Internet browsers include the ability to transmit “Do Not Track” signals. Since uniform standards for “Do Not Track” signals have not yet been adopted, Cytrellis does not process or respond to “Do Not Track” signals.
Under Age 13
Cytrellis understands the importance of protecting children’s privacy in the interactive online world. The Website is not designed for, or intentionally targeted at, children 13 years of age or younger. It is not our policy to intentionally collect or maintain information about anyone under the age of 13. No one under the age of 13 should submit any PI to Cytrellis and/or the Website, and if we learn that we have collected or received PI from a child under 13, we will delete that information. If your child has sent us personal information and you would like it removed, please send an e-mail to info@cytrellis.com requesting removal.
Under Age 18
Minors under 18 years of age may have the PI that they have provided to Cytrellis through this Website deleted by sending an e-mail to info@cytrellis.com requesting deletion. Please note that, while we make reasonable efforts to comply with such requests, deletion of your PI does not ensure complete and comprehensive removal of that data from all systems.
California Civil Code Section § 1798.83 permits users of our Website that are California residents to request certain information regarding our disclosure of PI to third parties for their direct marketing purposes. To make such a request, you may contact us by e-mail at info@cytrellis.com.
You may review and request changes to your PI that Cytrellis has collected, including the removal of your PI from Cytrellis’s databases in order to prevent receipt of future communications, using any of the following options:
You can send your request via e-mail to: info@cytrellis.com
You can mail your request to the following postal address:
Cytrellis Biosystems, Inc.
Attn: Privacy Policy
34 Commerce Way
Woburn, MA 02210
This Privacy Policy may be revised from time to time as we add new features and services, as laws change, and as industry privacy and security best practices evolve. We display a version number and a date on the policy in the upper right comer of this Privacy Policy so that it will be easier for you to know when there has been a change. If we make any change to this Privacy Policy regarding use or disclosure of PI, we will provide advance notice on this Website. Small changes or changes that do not significantly affect individual privacy interests may be made at any time and without prior notice.
If you have any questions about this Privacy Policy or about Cytrellis’s handling of your information, please contact info@cytrellis.com.
The ellacor® System with Micro-Coring® technology is indicated for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.
Your medical professional will discuss the following side effects with you prior to treatment. Proper pre- and post-treatment care reduces the risk of these side effects; however, some conditions may or may not resolve over time. Side effects associated with this procedure may include: redness, swelling, bruising, burning, dryness, roughness, tightness/pulling of skin, crusting, pain/discomfort, tenderness, tingling, bleeding, numbness, skin peeling, or circular marks on skin.
Other side effects not commonly observed with this procedure may include: itching, hyper/hypo pigmentation, hematoma, infection, scarring, skin irregularities, skin necrosis, uneven appearance of the treated regions (left and right sides of face), or anesthesia toxicity (anesthesia-related complications may include allergic reaction and possibly death).
The ellacor® procedure should not be used for the treatment of areas of skin with dermatosis (e.g. skin tumors, keloids or in case of predisposition to keloids, solar keratosis, warts, or birthmarks), area within the bony orbital rim; mucous membranes; areas where silicone or synthetic material is implanted.
The ellacor® procedure should not be used on patients that are pregnant or nursing mothers, suffering from open wounds, sores, or irritated skin in the treatment area, have an allergy to stainless steel or allergy to topical, oral, or injected medications or preparations that may be used during the procedure, such as petrolatum, lidocaine, bupivacaine, chlorhexidine, or povidone-iodine. Patients that have a history or presence of any clinically significant bleeding disorder, have dermatological or autoimmune conditions that may affect the treatment outcome; these may include, but are not limited to: actinic keratosis, raised nevi, rosacea, melasma, active acne, cutaneous papules/nodules, active inflammatory lesions, dermatitis, psoriasis, cellulitis, urticarial folliculitis, acute inflammatory phase of scleroderma, rheumatoid arthritis, eczema, psoriasis, allergic dermatitis, collagen disorders, or lupus should not be treated with the ellacor® procedure. Additionally, patients that have systemic infections or acute local skin infections such as Hepatitis disorders type A, B, C, D, E or F or HIV infection, take a high dose of anti-coagulants or blood-thinning substances (e.g. aspirin, nonsteroidal anti-inflammatory drugs, NSAIDs, warfarin, heparin, acetylsalicylic acid during the previous fourteen (14) days), are on courses of chemotherapy, high-dose corticosteroid use, or radiation in the treatment area, have undergone plastic surgery of the face within the last twelve (12) months or have any facial surgical scars less than twelve (12) months old, have undergone injections of dermal fillers, fat, or botulinum toxin, as well as any minimally invasive/invasive skin treatment in the treatment area during the previous six (6) months, or have scars less than six (6) months old in the treatment area should not be treated with the ellacor® procedure.
Appropriateness for treatment is based on the clinical assessment of the patient by the treating physician. Use caution when treating patients with the following conditions or taking the following medications: